121 related articles for article (PubMed ID: 9291400)
41. Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature.
Hill J; Walsh RM; McHam S; Brody F; Kalaycio M
Am J Hematol; 2004 Mar; 75(3):134-8. PubMed ID: 14978692
[TBL] [Abstract][Full Text] [Related]
42. Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Rai KR; Freter CE; Mercier RJ; Cooper MR; Mitchell BS; Stadtmauer EA; Santábarbara P; Wacker B; Brettman L
J Clin Oncol; 2002 Sep; 20(18):3891-7. PubMed ID: 12228210
[TBL] [Abstract][Full Text] [Related]
43. Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia.
Weiss M; Spiess T; Berman E; Kempin S
Leukemia; 1994 Aug; 8(8):1290-3. PubMed ID: 8057664
[TBL] [Abstract][Full Text] [Related]
44. Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia.
Leporrier M
Hematol J; 2004; 5 Suppl 1():S10-9. PubMed ID: 15079149
[TBL] [Abstract][Full Text] [Related]
45. Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial.
Elter T; Gercheva-Kyuchukova L; Pylylpenko H; Robak T; Jaksic B; Rekhtman G; Kyrcz-Krzemień S; Vatutin M; Wu J; Sirard C; Hallek M; Engert A
Lancet Oncol; 2011 Dec; 12(13):1204-13. PubMed ID: 21992852
[TBL] [Abstract][Full Text] [Related]
46. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Perkins JG; Flynn JM; Howard RS; Byrd JC
Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
[TBL] [Abstract][Full Text] [Related]
47. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F
Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133
[TBL] [Abstract][Full Text] [Related]
48. Indications for and results of splenectomy in different hematological disorders.
Böhner H; Tirier C; Rötzscher VM; Heit W
Langenbecks Arch Chir; 1997; 382(2):79-82. PubMed ID: 9128872
[TBL] [Abstract][Full Text] [Related]
49. Value of splenectomy in non-Hodgkin's lymphoma.
Kehoe JE; Daly JM; Straus DJ; DeCosse JJ
Cancer; 1985 Mar; 55(6):1256-64. PubMed ID: 2578865
[TBL] [Abstract][Full Text] [Related]
50. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
51. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
Vick DJ; Byrd JC; Beal CL; Chaffin DJ
Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of patients with fludarabine-refractory chronic lymphocytic leukemia: a population-based study from a well-defined geographic region.
Eketorp Sylvan S; Hansson L; Karlsson C; Norin S; Lundin J; Osterborg A
Leuk Lymphoma; 2014 Aug; 55(8):1774-80. PubMed ID: 24237446
[TBL] [Abstract][Full Text] [Related]
53. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
Hocepied AM; Falkson CI; Falkson G
S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
[TBL] [Abstract][Full Text] [Related]
54. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
55. Chronic lymphocytic leukemia in India--a clinico-hematological profile.
Agrawal N; Naithani R; Mahapatra M; Panigrahi I; Kumar R; Pati HP; Saxena R; Choudhary VP
Hematology; 2007 Jun; 12(3):229-33. PubMed ID: 17558698
[TBL] [Abstract][Full Text] [Related]
56. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
57. A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
Kimby E; Brandt L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):224-30. PubMed ID: 11441934
[TBL] [Abstract][Full Text] [Related]
58. Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia.
O'Brien S; Kantarjian H; Beran M; Koller C; Talpaz M; Lerner S; Keating MJ
Leukemia; 1997 Oct; 11(10):1631-5. PubMed ID: 9324281
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of oral fludarabine in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Zhu Y; Qin Q; Xie Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 38(3):221-4. PubMed ID: 23545817
[TBL] [Abstract][Full Text] [Related]
60. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications.
Jindra P; Koza V; Fiser J; Vozobulová V; Svojgrová M
Bone Marrow Transplant; 1999 Jul; 24(2):215-7. PubMed ID: 10455354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
